Success Story: Without RFE, A Senior Research Associate from China gained EB1A Approval in Just Over 3 Months
Client’s Testimonial:
“Thank you for the good news and for your help throughout my application process!”
On November 17th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Research Associate in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Senior Research Associate
Country of Origin: China
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: November 17th, 2025
Processing Time: 3 months, 3 days
Case Overview:
Our firm successfully secured EB-1A approval for a senior research associate from China in the field of biotechnology. The petition was approved in just over 3 months without a Request for Evidence.
Academic Qualifications and Professional Standing:
The beneficiary holds a Ph.D. in Biochemistry. At the time of filing, the client was conducting research in protein engineering, therapeutic development, and cellular disease mechanisms. The proposed endeavor involves continuing advanced biotechnology research with applications in diagnostic tools and therapeutic strategies addressing critical healthcare priorities.
Research Impact and Recognition:
The client’s scholarly contributions comprise 14 peer-reviewed journal articles (7 first- or co-first-authored) and 4 peer-reviewed conference articles (1 first-authored). This body of work has generated 224 citations, demonstrating widespread adoption and influence within the international scientific community. Research activities have been supported by the National Institutes of Health (NIH).
The client has performed at least 16 peer reviews for distinguished journals in biotechnology and related disciplines, evidencing recognition as an expert evaluator by leading academic publishers.
National Interest and Expert Testimony:
The petition demonstrated that the client’s research advances United States leadership in biotechnology and aligns with federal health research priorities. The work addresses national needs in precision medicine and translational research, with direct applications to disease understanding and therapeutic development.
Four expert recommendation letters from internationally recognized authorities provided independent validation of the client’s contributions. One expert stated:
“[The Client] has a unique aptitude for ingenuity in the field of biotechnologies. I fully endorse the extension of his outstanding research here in the United States.”
Conclusion:
Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously prepared a petition demonstrating that the beneficiary has achieved sustained national and international acclaim in biotechnology. USCIS’s approval confirms the client’s extraordinary ability and standing among the top echelon of researchers in the field. We are honored to have supported this accomplished scientist and extend our sincere best wishes for his continued contributions to advancing biotechnology innovation and healthcare solutions in the United States.